Key facts
- It has raised $38.3M; the latest was Later Stage VC ($20.0M) in Jul 2024.
- Notable investors include Tech Incubator Program for Startup, Matter (Consulting Services (B2B)), Hana Ventures, Premier Partners, BSK Investment — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for AIRS Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for AIRS Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AIRS Medical
Developer of an MRI software designed to accelerate scans and preserve image quality. The company offers AI-powered MRI acceleration software that combines classic parallel imaging compressed sensing algorithms and deep learning to produce accurate final reconstruction results, providing medical professionals with higher scan productivity, fewer motion artifacts, and better image quality.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2018
- Employees
- 102
- Website
- airsmed.com/
- Ownership
- Privately Held (backing)
AIRS Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AIRS Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AIRS Medical in its N-PORT filings yet. We sweep new filings monthly.